Cerity Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58M | Sell |
854,222
-73,991
| -8% | -$5.02M | 0.1% | 178 |
|
|
2025
Q1 | $63.7M | Buy |
928,213
+170,494
| +23% | +$11.7M | 0.13% | 153 |
|
|
2024
Q4 | $69.3M | Sell |
757,719
-32,917
| -4% | -$3.01M | 0.15% | 141 |
|
|
2024
Q3 | $94.1M | Buy |
790,636
+181,933
| +30% | +$21.7M | 0.21% | 102 |
|
|
2024
Q2 | $86.9M | Sell |
608,703
-44,616
| -7% | -$6.37M | 0.23% | 92 |
|
|
2024
Q1 | $83.9M | Buy |
653,319
+276,287
| +73% | +$35.5M | 0.22% | 98 |
|
|
2023
Q4 | $39M | Buy |
377,032
+157,788
| +72% | +$16.3M | 0.13% | 152 |
|
|
2023
Q3 | $19.9M | Buy |
219,244
+44,236
| +25% | +$4.02M | 0.1% | 187 |
|
|
2023
Q2 | $14.2M | Buy |
175,008
+11,780
| +7% | +$953K | 0.06% | 294 |
|
|
2023
Q1 | $17.6M | Buy |
163,228
+7,162
| +5% | +$772K | 0.04% | 252 |
|
|
2022
Q4 | $10.9M | Buy |
156,066
+76,072
| +95% | +$5.29M | 0.07% | 248 |
|
|
2022
Q3 | $3.99M | Sell |
79,994
-5,930
| -7% | -$295K | 0.05% | 271 |
|
|
2022
Q2 | $4.79M | Buy |
85,924
+37,748
| +78% | +$2.1M | 0.05% | 253 |
|
|
2022
Q1 | $2.47M | Sell |
48,176
-27,444
| -36% | -$1.41M | 0.04% | 295 |
|
|
2021
Q4 | $4.23M | Buy |
+75,620
| New | +$4.23M | 0.06% | 222 |
|
|
2019
Q4 | – | Sell |
-22,910
| Closed | -$592K | – | 559 |
|
|
2019
Q3 | $592K | Buy |
+22,910
| New | +$592K | 0.03% | 294 |
|
|
2019
Q2 | – | Sell |
-9,658
| Closed | -$253K | – | 557 |
|
|
2019
Q1 | $253K | Buy |
+9,658
| New | +$253K | 0.02% | 451 |
|
|
2018
Q1 | – | Sell |
-8,718
| Closed | -$234K | – | 566 |
|
|
2017
Q4 | $234K | Buy |
+8,718
| New | +$234K | 0.02% | 503 |
|